These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8192105)

  • 1. Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
    Perrone F; De Placido S; Carlomagno C; Gravina A; De Laurentiis M; Del Mastro L; Gridelli C; Pagliarulo C; Bianco AR
    Am J Clin Oncol; 1994 Jun; 17(3):218-22. PubMed ID: 8192105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients.
    Bascioni R; Giorgi F; Silva RR; Acito L; Giustini L; De Signoribus G; Giuliodori L; Testa E
    Breast Cancer Res Treat; 1997 Sep; 45(3):205-10. PubMed ID: 9386863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
    Perrone F; De Placido S; Carlomagno C; Nuzzo F; Ruggiero A; De Laurentiis M; Gridelli C; Pagliarulo C; Bianco AR
    Tumori; 1993 Aug; 79(4):254-7. PubMed ID: 8249178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
    Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
    J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
    Kim R; Osaki A; Tanabe K; Kojima J; Toge T
    Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
    Degardin M; Hecquet B; Bonneterre J; Adenis A; Pion JM; Demaille A
    Bull Cancer; 1992; 79(2):169-76. PubMed ID: 1392155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
    Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
    Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE; Powles TJ
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II study.
    Llombart-Cussac A; Pivot X; Rhor-Alvarado A; Le Cesne A; Le Chevalier T; Tursz T; Spielmann M
    Oncology; 1998; 55(5):384-90. PubMed ID: 9732214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
    Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
    Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer.
    Bishop JF; Raghavan D; Woods R; Coates A; Burns I; Jeal PN; Hillcoat BL; Tattersall MN
    Cancer Treat Rep; 1987 Feb; 71(2):191-3. PubMed ID: 2433037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.
    Scheithauer W; Kornek G; Haider K; Kwasny W; Schenk T; Pirker R; Depisch D
    Breast Cancer Res Treat; 1993; 26(1):49-53. PubMed ID: 8400323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.
    Colozza M; Gori S; Mosconi AM; Anastasi P; Basurto C; Ludovini V; De Angelis V; Giansanti M; Tonato M
    Breast Cancer Res Treat; 1996; 38(3):277-82. PubMed ID: 8739080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
    Panasci L; Shenouda G; Begin L; Pollak M; Reinke A; Margolese R
    Cancer Chemother Pharmacol; 1990; 26(6):457-60. PubMed ID: 2121379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.
    Repetto L; Miglietta L; Gardin G; Naso C; Giudici S; Merlini L; Queirolo P; Campora E; Pronzato P; Rosso R
    Ann Oncol; 1992 Feb; 3(2):165-6. PubMed ID: 1606088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.
    Comella P; Biglietto M; Casaretti R; De Lucia L; Avallone A; Maiorino L; Di Lullo L; De Cataldis G; Rivellini F; Comella G
    Oncology; 2001; 60(2):127-33. PubMed ID: 11244327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
    Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.